CAPRICOR THERAPEUTICS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
CAPRICOR THERAPEUTICS, INC. (CAPR) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $2.88 per share as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2024-03-11
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $2.88.
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $2.51.
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $2.00.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $1.50.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2023-12-31 | $2.88 10-K · filed 2024-03-11 |
| 2022-12-31 | $2.51 10-K · filed 2023-03-17 |
| 2021-12-31 | $2.00 10-K · filed 2022-03-11 |
| 2020-12-31 | $1.50 10-K · filed 2021-03-15 |
| 2017-12-31 | $1.30 10-K · filed 2018-03-22 |
| 2016-12-31 | $1.05 10-K · filed 2017-03-16 |
| 2015-12-31 | $0.78 10-K · filed 2016-03-30 |
| 2014-12-31 | $0.47 10-K · filed 2015-03-16 |
| 2013-12-31 | $0.67 10-K · filed 2014-03-31 |
| 2013-09-30 | $1.02 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.25 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.26 10-Q · filed 2013-06-21 |
| 2012-12-31 | $1.25 10-K · filed 2013-06-21 |
| 2012-09-30 | $1.07 10-Q · filed 2013-06-21 |
| 2012-06-30 | $1.54 10-Q/A · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |